Company intelligence / Profile preview

Logos Capital

San Francisco, California, United Stateslogoscapitalmanagement.com ↗

Ownership: Private
Development stage: Other

Overview

Logos Capital is a San Francisco-based venture fund dedicated to advancing healthcare through disciplined, data-driven investments in biotechnology. They use rigorous scientific diligence and proprietary analytics to identify transformative therapies that can elevate standards of care. The firm leverages deep expertise across science and finance to underwrite clinical trial risk and support innovation throughout the drug development lifecycle. Their mission centers on funding life-changing therapeutics while generating superior long-term returns for investors.

Industry: Investors

Beyond the preview

Go deeper on Logos Capital.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Logos Capital.

Explore the full profile